Program Description
In patients with chronic kidney disease (CKD) and type 2 diabetes (T2D), multimorbidity is frequent. They are at high risk of CKD progression, premature mortality, and greater disease burden. Several key opportunities for pharmacists exist at the intersection of diabetes and CKD. Among them is the potential to improve CKD awareness. Early identification of symptoms through screening and prompt initiation of management strategies is paramount. This webinar will outline the pathophysiology of CKD progression and risk factors for people living with T2D. The discussion will center on complications of both the kidneys and the cardiovascular system in diabetes, as well as their effects on patients’ quality of life. The role of the pharmacist in mitigating disease progression and improving overall patient outcomes will be explored.
Target audience: Health-system, retail, and specialty pharmacists
Type of activity: Application
Release date: September 13, 2023
Expiration date: September 13, 2024
Time to complete activity: 1.0 hour
Learner level: Foundational
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Examine the drivers of chronic kidney disease (CKD) progression in patients with type 2 diabetes (T2D)
- Explain the economic burden of CKD progression as well as its impact on patients’ quality of life
- Identify opportunities for pharmacists to provide comprehensive care to reduce complications and CKD progression in patients with T2D
Joseph Davis, PharmD, BCPS
Supervisor
Adult Medicine Clinical Pharmacy Services
Department of Pharmacy
ECU Health Medical Center
Greenville, North Carolina
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-23-365-H01-P. The activity is available for CE credit through September 13, 2024.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Joseph Davis, PharmD, BCPS
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Karleen Rush, PharmD; Angelica Archibald; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green.
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms